Questionnaires . | MAD (n = 15) . | Placebo (n = 15) . | pgroup × time . | Effect size . | ||
---|---|---|---|---|---|---|
Baseline mean ± SD . | 1.5-year mean ± SD . | Baseline mean ± SD . | 1.5-year mean ± SD . | (d) . | ||
Epworth Sleepiness Scale | 13.2 ± 7.8 | 12.1 ± 8.9 | 11 ± 12 | 7.2 ± 8.0 | .3 | 2.45 |
Fatigue (MFIS) | 51 ± 24.5 | 35.3 ± 35.6 | 51.8 ± 46.9 | 48 ± 34.9 | .08 | 6.35 |
PSQI component 1 | 2.3 ± 1.7 | 2 ± 2 | 2 ± 2 | 2.2 ± 2.2 | .4 | 0.1 |
PSQI component 2 | 2 ± 1.3 | 1.8 ± 1.1 | 1.8 ± 1.7 | 1.5 ± 1.4 | .7 | 0.15 |
PSQI component 3 | 1.7 ± 1.4 | 1.9 ± 1.9 | 1.7 ± 1.5 | 1.6 ± 2 | .4 | 0.15 |
PSQI component 4 | 1.8 ± 1.1 | 1.1 ± 0.7 | 1.7 ± 0.9 | 2.2 ± 3 | .02* | 0.55 |
PSQI component 5 | 2.1 ± 1.3 | 1.8 ± 1.6 | 1.8 ± 1.5 | 1.7 ± 1.4 | .5 | 0.05 |
PSQI component 6 | 2.1 ± 1.4 | 1.6 ± 1.5 | 1.7 ± 1.7 | 1.8 ± 1.7 | .1 | 0.1 |
PSQI component 7 | 1.8 ± 1.3 | 1.8 ± 1.6 | 1.7 ± 1.9 | 1.7 ± 2.7 | .9 | 0.05 |
PSQI total | 12.9 ± 8.4 | 9.5 ± 8.1 | 9.7 ± 10.5 | 10.3 ± 12 | .03* | 0.4 |
FOSQ general productivity | 2.8 ± 2 | 3.2 ± 2 | 2.5 ± 2.6 | 3.1 ± 1.1 | .6 | 0.05 |
FOSQ social outcome | 3 ± 3.3 | 3.4 ± 3 | 2.5 ± 3.2 | 3.3 ± 2.6 | .5 | 0.05 |
FOSQ activity levela | 2.5 ± 2 | 3 ± 1.7 | 2.4 ± 1.6 | 3.3 ± 1.4 | .2 | 0.15 |
FOSQ vigilance | 2.6 ± 2.2 | 2.9 ± 1.9 | 2.8 ± 2.2 | 3.4 ± 1.4 | .6 | 0.25 |
FOSQ intimate relationships and sexual activity | 2.8 ± 3.8 | 3.3 ± 3.2 | 1.9 ± 2.5 | 2.5 ± 2.7 | .7 | 0.4 |
FOSQ totala | 13.3 ± 11.5 | 15.8 ± 10.2 | 12.1 ± 10.5 | 15.5 ± 7.7 | .6 | 0.15 |
Beck Anxiety Inventory | 16.9 ± 24.8 | 10.7 ± 17 | 22.5 ± 33.4 | 20.3 ± 26.6 | .1 | 4.8 |
Beck Depression Inventory | 21.6 ± 18.6 | 10.8 ± 10.9 | 16.2 ± 21.5 | 14.4 ± 18.3 | <.01* | 1.8 |
Questionnaires . | MAD (n = 15) . | Placebo (n = 15) . | pgroup × time . | Effect size . | ||
---|---|---|---|---|---|---|
Baseline mean ± SD . | 1.5-year mean ± SD . | Baseline mean ± SD . | 1.5-year mean ± SD . | (d) . | ||
Epworth Sleepiness Scale | 13.2 ± 7.8 | 12.1 ± 8.9 | 11 ± 12 | 7.2 ± 8.0 | .3 | 2.45 |
Fatigue (MFIS) | 51 ± 24.5 | 35.3 ± 35.6 | 51.8 ± 46.9 | 48 ± 34.9 | .08 | 6.35 |
PSQI component 1 | 2.3 ± 1.7 | 2 ± 2 | 2 ± 2 | 2.2 ± 2.2 | .4 | 0.1 |
PSQI component 2 | 2 ± 1.3 | 1.8 ± 1.1 | 1.8 ± 1.7 | 1.5 ± 1.4 | .7 | 0.15 |
PSQI component 3 | 1.7 ± 1.4 | 1.9 ± 1.9 | 1.7 ± 1.5 | 1.6 ± 2 | .4 | 0.15 |
PSQI component 4 | 1.8 ± 1.1 | 1.1 ± 0.7 | 1.7 ± 0.9 | 2.2 ± 3 | .02* | 0.55 |
PSQI component 5 | 2.1 ± 1.3 | 1.8 ± 1.6 | 1.8 ± 1.5 | 1.7 ± 1.4 | .5 | 0.05 |
PSQI component 6 | 2.1 ± 1.4 | 1.6 ± 1.5 | 1.7 ± 1.7 | 1.8 ± 1.7 | .1 | 0.1 |
PSQI component 7 | 1.8 ± 1.3 | 1.8 ± 1.6 | 1.7 ± 1.9 | 1.7 ± 2.7 | .9 | 0.05 |
PSQI total | 12.9 ± 8.4 | 9.5 ± 8.1 | 9.7 ± 10.5 | 10.3 ± 12 | .03* | 0.4 |
FOSQ general productivity | 2.8 ± 2 | 3.2 ± 2 | 2.5 ± 2.6 | 3.1 ± 1.1 | .6 | 0.05 |
FOSQ social outcome | 3 ± 3.3 | 3.4 ± 3 | 2.5 ± 3.2 | 3.3 ± 2.6 | .5 | 0.05 |
FOSQ activity levela | 2.5 ± 2 | 3 ± 1.7 | 2.4 ± 1.6 | 3.3 ± 1.4 | .2 | 0.15 |
FOSQ vigilance | 2.6 ± 2.2 | 2.9 ± 1.9 | 2.8 ± 2.2 | 3.4 ± 1.4 | .6 | 0.25 |
FOSQ intimate relationships and sexual activity | 2.8 ± 3.8 | 3.3 ± 3.2 | 1.9 ± 2.5 | 2.5 ± 2.7 | .7 | 0.4 |
FOSQ totala | 13.3 ± 11.5 | 15.8 ± 10.2 | 12.1 ± 10.5 | 15.5 ± 7.7 | .6 | 0.15 |
Beck Anxiety Inventory | 16.9 ± 24.8 | 10.7 ± 17 | 22.5 ± 33.4 | 20.3 ± 26.6 | .1 | 4.8 |
Beck Depression Inventory | 21.6 ± 18.6 | 10.8 ± 10.9 | 16.2 ± 21.5 | 14.4 ± 18.3 | <.01* | 1.8 |
MAD = mandibular advancement device; MFIS = Modified Fatigue Impact Scale; PSQI = Pittsburgh Sleep Quality Index; FOSQ = Functional Outcomes of Sleep Questionnaire.
Data represented by mean ± standard deviation.
Generalized Estimation Equation (GEE) (time, group, interaction time × group), covariates: delta BMI (1.5-year treatment-baseline).
Effect size: Cohen’s d.
*p ≤ .05 interaction group (placebo and UARS) and time (baseline and after 1.5-year treatment).
ap ≤ .05 between time independently of group.
Questionnaires . | MAD (n = 15) . | Placebo (n = 15) . | pgroup × time . | Effect size . | ||
---|---|---|---|---|---|---|
Baseline mean ± SD . | 1.5-year mean ± SD . | Baseline mean ± SD . | 1.5-year mean ± SD . | (d) . | ||
Epworth Sleepiness Scale | 13.2 ± 7.8 | 12.1 ± 8.9 | 11 ± 12 | 7.2 ± 8.0 | .3 | 2.45 |
Fatigue (MFIS) | 51 ± 24.5 | 35.3 ± 35.6 | 51.8 ± 46.9 | 48 ± 34.9 | .08 | 6.35 |
PSQI component 1 | 2.3 ± 1.7 | 2 ± 2 | 2 ± 2 | 2.2 ± 2.2 | .4 | 0.1 |
PSQI component 2 | 2 ± 1.3 | 1.8 ± 1.1 | 1.8 ± 1.7 | 1.5 ± 1.4 | .7 | 0.15 |
PSQI component 3 | 1.7 ± 1.4 | 1.9 ± 1.9 | 1.7 ± 1.5 | 1.6 ± 2 | .4 | 0.15 |
PSQI component 4 | 1.8 ± 1.1 | 1.1 ± 0.7 | 1.7 ± 0.9 | 2.2 ± 3 | .02* | 0.55 |
PSQI component 5 | 2.1 ± 1.3 | 1.8 ± 1.6 | 1.8 ± 1.5 | 1.7 ± 1.4 | .5 | 0.05 |
PSQI component 6 | 2.1 ± 1.4 | 1.6 ± 1.5 | 1.7 ± 1.7 | 1.8 ± 1.7 | .1 | 0.1 |
PSQI component 7 | 1.8 ± 1.3 | 1.8 ± 1.6 | 1.7 ± 1.9 | 1.7 ± 2.7 | .9 | 0.05 |
PSQI total | 12.9 ± 8.4 | 9.5 ± 8.1 | 9.7 ± 10.5 | 10.3 ± 12 | .03* | 0.4 |
FOSQ general productivity | 2.8 ± 2 | 3.2 ± 2 | 2.5 ± 2.6 | 3.1 ± 1.1 | .6 | 0.05 |
FOSQ social outcome | 3 ± 3.3 | 3.4 ± 3 | 2.5 ± 3.2 | 3.3 ± 2.6 | .5 | 0.05 |
FOSQ activity levela | 2.5 ± 2 | 3 ± 1.7 | 2.4 ± 1.6 | 3.3 ± 1.4 | .2 | 0.15 |
FOSQ vigilance | 2.6 ± 2.2 | 2.9 ± 1.9 | 2.8 ± 2.2 | 3.4 ± 1.4 | .6 | 0.25 |
FOSQ intimate relationships and sexual activity | 2.8 ± 3.8 | 3.3 ± 3.2 | 1.9 ± 2.5 | 2.5 ± 2.7 | .7 | 0.4 |
FOSQ totala | 13.3 ± 11.5 | 15.8 ± 10.2 | 12.1 ± 10.5 | 15.5 ± 7.7 | .6 | 0.15 |
Beck Anxiety Inventory | 16.9 ± 24.8 | 10.7 ± 17 | 22.5 ± 33.4 | 20.3 ± 26.6 | .1 | 4.8 |
Beck Depression Inventory | 21.6 ± 18.6 | 10.8 ± 10.9 | 16.2 ± 21.5 | 14.4 ± 18.3 | <.01* | 1.8 |
Questionnaires . | MAD (n = 15) . | Placebo (n = 15) . | pgroup × time . | Effect size . | ||
---|---|---|---|---|---|---|
Baseline mean ± SD . | 1.5-year mean ± SD . | Baseline mean ± SD . | 1.5-year mean ± SD . | (d) . | ||
Epworth Sleepiness Scale | 13.2 ± 7.8 | 12.1 ± 8.9 | 11 ± 12 | 7.2 ± 8.0 | .3 | 2.45 |
Fatigue (MFIS) | 51 ± 24.5 | 35.3 ± 35.6 | 51.8 ± 46.9 | 48 ± 34.9 | .08 | 6.35 |
PSQI component 1 | 2.3 ± 1.7 | 2 ± 2 | 2 ± 2 | 2.2 ± 2.2 | .4 | 0.1 |
PSQI component 2 | 2 ± 1.3 | 1.8 ± 1.1 | 1.8 ± 1.7 | 1.5 ± 1.4 | .7 | 0.15 |
PSQI component 3 | 1.7 ± 1.4 | 1.9 ± 1.9 | 1.7 ± 1.5 | 1.6 ± 2 | .4 | 0.15 |
PSQI component 4 | 1.8 ± 1.1 | 1.1 ± 0.7 | 1.7 ± 0.9 | 2.2 ± 3 | .02* | 0.55 |
PSQI component 5 | 2.1 ± 1.3 | 1.8 ± 1.6 | 1.8 ± 1.5 | 1.7 ± 1.4 | .5 | 0.05 |
PSQI component 6 | 2.1 ± 1.4 | 1.6 ± 1.5 | 1.7 ± 1.7 | 1.8 ± 1.7 | .1 | 0.1 |
PSQI component 7 | 1.8 ± 1.3 | 1.8 ± 1.6 | 1.7 ± 1.9 | 1.7 ± 2.7 | .9 | 0.05 |
PSQI total | 12.9 ± 8.4 | 9.5 ± 8.1 | 9.7 ± 10.5 | 10.3 ± 12 | .03* | 0.4 |
FOSQ general productivity | 2.8 ± 2 | 3.2 ± 2 | 2.5 ± 2.6 | 3.1 ± 1.1 | .6 | 0.05 |
FOSQ social outcome | 3 ± 3.3 | 3.4 ± 3 | 2.5 ± 3.2 | 3.3 ± 2.6 | .5 | 0.05 |
FOSQ activity levela | 2.5 ± 2 | 3 ± 1.7 | 2.4 ± 1.6 | 3.3 ± 1.4 | .2 | 0.15 |
FOSQ vigilance | 2.6 ± 2.2 | 2.9 ± 1.9 | 2.8 ± 2.2 | 3.4 ± 1.4 | .6 | 0.25 |
FOSQ intimate relationships and sexual activity | 2.8 ± 3.8 | 3.3 ± 3.2 | 1.9 ± 2.5 | 2.5 ± 2.7 | .7 | 0.4 |
FOSQ totala | 13.3 ± 11.5 | 15.8 ± 10.2 | 12.1 ± 10.5 | 15.5 ± 7.7 | .6 | 0.15 |
Beck Anxiety Inventory | 16.9 ± 24.8 | 10.7 ± 17 | 22.5 ± 33.4 | 20.3 ± 26.6 | .1 | 4.8 |
Beck Depression Inventory | 21.6 ± 18.6 | 10.8 ± 10.9 | 16.2 ± 21.5 | 14.4 ± 18.3 | <.01* | 1.8 |
MAD = mandibular advancement device; MFIS = Modified Fatigue Impact Scale; PSQI = Pittsburgh Sleep Quality Index; FOSQ = Functional Outcomes of Sleep Questionnaire.
Data represented by mean ± standard deviation.
Generalized Estimation Equation (GEE) (time, group, interaction time × group), covariates: delta BMI (1.5-year treatment-baseline).
Effect size: Cohen’s d.
*p ≤ .05 interaction group (placebo and UARS) and time (baseline and after 1.5-year treatment).
ap ≤ .05 between time independently of group.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.